Pharmacological action:
Sehydrin has ability to inhibit the growth of cance cells. At a late stage of cancer has a symptomatic effect.
The active ingredient - hydrazine sulfate. Excipients: dibasic calcium phosphate , PVP , magnesium stearate, silicon dioxide fine .
Contains talc , dimethicone , polyethylene glycol 600; polymethacrylate , titanium dioxide , iron oxide red .

Indications for use:
Patients with locally advanced and disseminated malignancies , as well as : lung cancer, gastric cancer, and other digestive tract - brain tumor (primary) - neuroblastoma - Lymphosarcoma - limfogranulomatoz - desmoid soft tissue infiltrative growth.
Mode of application
The drug is taken for 1 or 2 hours before or after meals. Dosage comprises administering one tablet three times a day. Heading dose of 100 tablets. Repeat the treatment after 14 days and the number of courses - unlimited .